ACE |
Angiotensin Converting Enzyme |
ACTH |
Adrenocorticotropic Hormone |
ADE |
Antibody-dependent Enhancement |
AKI |
Acute Kidney Injury |
Anti-GBM |
Anti-glomerular Basement Membrane Disease |
ARB |
Angiotensin Receptor Blockers |
ARDS |
Acute Respiratory Distress Syndrome |
ASN |
American Society of Nephrology |
BMD |
Bone Mass Density |
CDC |
United States Center for Disease Control |
CIRCI |
Critical Illness-related Corticosteroid Insufficiency |
CK |
Creatine kinase |
COVID-19 |
Coronavirus Disease 2019 |
CRRT |
Continuous Renal Replacement Therapy |
CSF |
CerebroSpinal Fluid |
CT |
Computed Tomography |
CVD |
Cardiovascular Disease |
CVT |
Cerebral Venus (sinus) Thrombosis |
DIC |
Disseminated Intravascular Coagulation |
DPP4 |
Dipeptidyl Peptidase 4 |
DRA |
Dopamine Receptor Agonist |
ERA-EDTA |
European Renal Association- European Dialysis and Transplant Association |
ESS |
Euthyroid Sick Syndrome |
FDA |
United States Food and Drug Administration |
GAS |
Gender Affirming Surgeries |
GBS |
Guillain-Barré syndrome |
GH |
Growth Hormone |
GI |
Gastrointestinal |
HPA |
Hypothalamus-pituitary-adrenal gland axis |
IFN/ IFN-γ |
Interferon-gamma |
IHD |
Intermittent Hemodialysis |
MAC |
Membrane Attack Complex |
MASP 1 |
MBP-associated serine protease 1 |
MASP 2 |
MBP-associated serine protease 2 |
MBP |
Mannan-binding protein |
ME/CFS |
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
MERS-CoV |
Middle East Respiratory Syndrome Coronavirus |
MIS-C |
Multi-system Inflammation Syndrome |
MFS |
Miller Fisher syndrome |
MRI |
Magnetic Resonance Imaging |
NRP1 |
Neuropilin-1 |
N-protein |
SARS-CoV-2 nucleocapsid protein |
PACS |
Post-acute COVID-19 Syndrome |
PPE |
Personal Protective Equipment |
PRS |
Proteomic Risk Score |
RAAS |
Renin Angiotensin Aldosterone System |
RMD |
Rheumatic and Musculoskeletal Disorders |
SARS-CoV-1 |
Severe Acute Respiratory Syndrome Coronavirus 1 |
SARS-CoV-2 |
Severe Acute Respiratory Syndrome Coronavirus 2 |
S-protein |
SARS-CoV-2 spike protein |
TGNC |
Transgender and non-conforming individuals |
TLR |
Toll-like Receptor |
TMPRSS2 |
Transmembrane Serine Protease-2 |
VEM |
Viscoelastic Methods |
VITT |
Vaccine-induced Immune Thrombocytopenia and Thrombosis |
VOC |
Variants of Concern |
VOI |
Variants of Interest |
WHO |
World Health Organization |